# NOV Inc. (NOV) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from NOV Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/NOV/mda/fy2025/): filed 2026-02-12; accession 0001193125-26-048350 (https://www.sec.gov/Archives/edgar/data/1021860/000119312526048350/nov-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/NOV/mda/fy2024/): filed 2025-02-14; accession 0000950170-25-021042 (https://www.sec.gov/Archives/edgar/data/1021860/000095017025021042/nov-20241231.htm)
- [FY 2023 MD&A](/company/NOV/mda/fy2023/): filed 2024-02-14; accession 0000950170-24-015145 (https://www.sec.gov/Archives/edgar/data/1021860/000095017024015145/nov-20231231.htm)
- [FY 2022 MD&A](/company/NOV/mda/fy2022/): filed 2023-02-14; accession 0000950170-23-002767 (https://www.sec.gov/Archives/edgar/data/1021860/000095017023002767/nov-20221231.htm)
- [FY 2021 MD&A](/company/NOV/mda/fy2021/): filed 2022-02-11; accession 0001564590-22-004755 (https://www.sec.gov/Archives/edgar/data/1021860/000156459022004755/nov-10k_20211231.htm)

Back to /company/NOV/